These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18727661)

  • 21. Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation.
    Derweesh IH; Ismail HR; Goldfarb DA; Araki M; Zhou L; Modlin C; Krishnamurthi V; Flechner SM; Novick AC
    BJU Int; 2008 Jun; 101(11):1415-9. PubMed ID: 18190623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).
    Trotter JF; Wachs M; Bak T; Trouillot T; Stolpman N; Everson GT; Kam I
    Liver Transpl; 2001 Apr; 7(4):343-51. PubMed ID: 11303295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.
    Grim SA; Slover CM; Sankary H; Oberholzer J; Benedetti E; Clark NM
    Transplant Proc; 2006 Dec; 38(10):3520-3. PubMed ID: 17175320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of application of sirolimus with dose-reduced or discontinued cyclosporine A for prevention of acute rejection after kidney transplantation].
    Lin J; Tang YW; Sun W; DU LD; Tian Y
    Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1319-21. PubMed ID: 20092728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus-based rescue therapy after rejection in liver transplantation.
    Lladó L; Fabregat J; Castellote J; Ramos E; Torras J; Serrano T; Figueras J; Rafecas A
    Clin Transplant; 2009; 23(1):89-95. PubMed ID: 19200220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.
    Johnson RW; Kreis H; Oberbauer R; Brattström C; Claesson K; Eris J
    Transplantation; 2001 Sep; 72(5):777-86. PubMed ID: 11571437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials.
    Cooper M; Wiseman AC; Zibari G; McCague K; Kim Y; Geissler F; Nashan B
    Clin Transplant; 2013; 27(6):E625-35. PubMed ID: 24033455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function.
    Russ G; Segoloni G; Oberbauer R; Legendre C; Mota A; Eris J; Grinyó JM; Friend P; Lawen J; Hartmann A; Schena FP; Lelong M; Burke JT; Neylan JF;
    Transplantation; 2005 Nov; 80(9):1204-11. PubMed ID: 16314787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.
    Mota A; Arias M; Taskinen EI; Paavonen T; Brault Y; Legendre C; Claesson K; Castagneto M; Campistol JM; Hutchison B; Burke JT; Yilmaz S; Häyry P; Neylan JF;
    Am J Transplant; 2004 Jun; 4(6):953-61. PubMed ID: 15147430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.
    Hulbert AL; Delahunty AJ; Rajab A; Forbes RC; Winters HA
    Clin Transplant; 2013; 27(4):E521-7. PubMed ID: 23923974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.
    Gyurus E; Kaposztas Z; Kahan BD
    Transplant Proc; 2011 Jun; 43(5):1583-92. PubMed ID: 21693238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
    Kreis H; Oberbauer R; Campistol JM; Mathew T; Daloze P; Schena FP; Burke JT; Brault Y; Gioud-Paquet M; Scarola JA; Neylan JF;
    J Am Soc Nephrol; 2004 Mar; 15(3):809-17. PubMed ID: 14978184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.
    Rogers CC; Hanaway M; Alloway RR; Alexander JW; Boardman RE; Trofe J; Gupta M; Merchen T; Buell JF; Cardi M; Roy-Chaudhury P; Succop P; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):795-7. PubMed ID: 15848534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No benefit when placing drains after kidney transplant: a complex statistical analysis.
    Sidebottom RC; Parsikia A; Chang PN; Berhane Z; Campos S; Khanmoradi K; Zaki RF; Ortiz JA
    Exp Clin Transplant; 2014 Apr; 12(2):106-12. PubMed ID: 24702141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation.
    Sandrini S; Aslam N; Tardanico R; Setti G; Bossini N; Valerio F; Insalaco M; Maffeis R; Nodari F; Cancarini G
    J Nephrol; 2012; 25(1):43-9. PubMed ID: 22135032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis.
    Iorember FM; Patel HP; Ohana A; Hayes JR; Mahan JD; Baker PB; Rajab A
    Pediatr Transplant; 2010 Feb; 14(1):93-9. PubMed ID: 19254246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature.
    Nashan B; Citterio F
    Transplantation; 2012 Sep; 94(6):547-61. PubMed ID: 22941182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.
    Tiong HY; Flechner SM; Zhou L; Wee A; Mastroianni B; Savas K; Goldfarb D; Derweesh I; Modlin C
    Transplantation; 2009 Jan; 87(2):296-302. PubMed ID: 19155988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.